OVEREXPRESSION OF P53 TUMOR-SUPPRESSOR PROTEIN IN POROKERATOSIS

被引:69
|
作者
MAGEE, JW
MCCALMONT, TH
LEBOIT, PE
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1001/archderm.130.2.187
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: p53 is a tumor suppressor nucleoprotein. Mutations of the p53 gene have been found in a variety of malignant neoplasms. Wild-type p53 has a short half-life, possibly only 20 to 30 minutes, and is not present in the nucleus at levels that are detectable with routine immunohistochemical techniques. Mutant p53 has a longer half-life, and is readily detectable with immunoperoxidase staining. Results: We studied 17 specimens from patients with either porokeratosis of Mibelli or actinic porokeratosis, using immunoperoxidase staining with an antibody directed against the p53. There was staining of lesional keratinocyte nuclei in 16 of 17 specimens, limited in most cases to the zone between carnoid lamellae. Staining for proliferating cell nuclear antigen was increased above background levels in only six of 13 specimens. Conclusions: The finding of p53 immunoperoxidase staining in porokeratosis suggests genetic mutation, as occurs in other cutaneous keratinocytic neoplasms, and the lack of corresponding proliferating cell nuclear antigen expression in many specimens indicates that p53 overexpression is not simply a reflection of increased cellular proliferation.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [41] THE TUMOR-SUPPRESSOR P53 REGULATES ITS OWN TRANSCRIPTION
    DEFFIE, A
    WU, HY
    REINKE, V
    LOZANO, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) : 3415 - 3423
  • [42] PHOSPHORYLATION OF THE TUMOR-SUPPRESSOR PROTEIN P53 BY MITOGEN-ACTIVATED PROTEIN-KINASES
    MILNE, DM
    CAMPBELL, DG
    CAUDWELL, FB
    MEEK, DW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (12) : 9253 - 9260
  • [43] p53 tumor-suppressor gene: Clues to molecular carcinogenesis
    Wang, XW
    Harris, CC
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 173 (02) : 247 - 255
  • [44] THE ROLE OF P53 TUMOR-SUPPRESSOR IN CELLULAR REPLICATIVE SENESCENCE
    DIMRI, GP
    HARA, E
    ACOSTA, M
    DESPREZ, P
    CAMPISI, J
    [J]. FASEB JOURNAL, 1995, 9 (06): : A1464 - A1464
  • [45] THE P53 TUMOR-SUPPRESSOR GENE AND ITS SIGNIFICANCE FOR DERMATOLOGY
    LUBBE, J
    KLEIHUES, P
    BURG, G
    [J]. HAUTARZT, 1994, 45 (11): : 741 - 745
  • [46] CLINICAL-APPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE
    DIAMANDIS, EP
    [J]. CLINICA CHIMICA ACTA, 1995, 237 (1-2) : 79 - 90
  • [47] GENE-TARGETING AND THE P53 TUMOR-SUPPRESSOR GENE
    SANDS, A
    DONEHOWER, LA
    BRADLEY, A
    [J]. MUTATION RESEARCH, 1994, 307 (02): : 557 - 572
  • [48] P53 AND RB TUMOR-SUPPRESSOR GENE ALTERATIONS IN RETINOBLASTOMA
    ITO, M
    MISHIMA, HK
    INAI, K
    ITO, T
    AKIYAMA, M
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (06) : 1329 - 1332
  • [49] P53 TUMOR-SUPPRESSOR GENE-EXPRESSION IN PTERYGIUM
    HU, FR
    WANG, IJ
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S1027 - S1027
  • [50] COMPARATIVE EXPRESSION OF P53 TUMOR-SUPPRESSOR PROTEIN ISOFORMS IN HUMAN AND MURINE CELLS
    SELKIRK, JK
    HE, CY
    MERRICK, BA
    [J]. FASEB JOURNAL, 1995, 9 (06): : A1272 - A1272